Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xu, Tu"'
Autor:
Conner SC; Vertex Pharmaceuticals, 50 Northern Ave, Boston, MA 02210, USA. Electronic address: sarah_conner@vrtx.com., Zhou Y; Vertex Pharmaceuticals, 50 Northern Ave, Boston, MA 02210, USA., Xu T; Novo Nordisk Inc., 75 Hayden Avenue, Lexington, MA 02421, USA.
Publikováno v:
Contemporary clinical trials [Contemp Clin Trials] 2024 Mar; Vol. 138, pp. 107414. Date of Electronic Publication: 2023 Dec 21.
Autor:
Xu T; Department of Clinical Medicine, Medical College of Hunan Normal University, Changsha, Hunan, China. Electronic address: 3225869817@qq.com., Jiang J; Department of Clinical Medicine, Medical College of Hunan Normal University, Changsha, Hunan, China. Electronic address: jiangjingwen@hunnu.edu.cn., Xiang X; Department of Clinical Medicine, Medical College of Hunan Normal University, Changsha, Hunan, China. Electronic address: Rhythm4422@163.com., Jahanshahi H; Institute of Electrical and Electronics Engineers, Toronto, ON, Canada. Electronic address: jahanshahi.hadi@ieee.org., Zhang Y; Department of Clinical Medicine, Medical College of Hunan Normal University, Changsha, Hunan, China. Electronic address: thaddeus@hunnu.edu.cn., Chen X; Department of Pathology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. Electronic address: 479488462@qq.com., Li L; Department of Gynecologic Oncology, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. Electronic address: LLS0731@126.com.
Publikováno v:
Computers in biology and medicine [Comput Biol Med] 2024 Jan; Vol. 168, pp. 107656. Date of Electronic Publication: 2023 Nov 10.
Autor:
DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pratz K; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation and.; Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA., Jonas BA; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Arellano M; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA., Becker PS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA., Frankfurt O; Northwestern University Feinberg School of Medicine, Chicago, IL., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Wei AH; The Alfred Hospital and Monash University, Melbourne, Australia., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Xu T; AbbVie Inc., North Chicago, IL., Hong WJ; Genentech, San Francisco, CA., Chyla B; AbbVie Inc., North Chicago, IL., Potluri J; AbbVie Inc., North Chicago, IL., Pollyea DA; Blood Cancer and Bone Marrow Transplant Program, University of Colorado School of Medicine, Aurora, CO; and., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood [Blood] 2019 Jan 03; Vol. 133 (1), pp. 7-17. Date of Electronic Publication: 2018 Oct 25.
Autor:
Kumar S; Mayo Clinic, Rochester, MN., Kaufman JL; Winship Cancer Institute of Emory University, Atlanta, GA., Gasparetto C; Hematologic Malignancies & Cellular Therapy, Duke University, Durham, NC., Mikhael J; Mayo Clinic, Scottsdale, AZ., Vij R; Washington University School of Medicine, St. Louis, MO., Pegourie B; Centre Hospitalier Universitaire, Grenoble, France., Benboubker L; Centre Hospitalier Regional Universitaire, Tours, France., Facon T; Centre Hospitalier Regional Universitaire Lille, Hopital Huriez, Lille, France., Amiot M; Centre Hospitalier Universitaire de Nantes, INSERM, Université de Nantes, France., Moreau P; Centre Hospitalier Universitaire de Nantes, INSERM, Université de Nantes, France., Punnoose EA; Genentech Inc., South San Francisco, CA; and., Alzate S; AbbVie Inc., North Chicago, IL., Dunbar M; AbbVie Inc., North Chicago, IL., Xu T; AbbVie Inc., North Chicago, IL., Agarwal SK; AbbVie Inc., North Chicago, IL., Enschede SH; AbbVie Inc., North Chicago, IL., Leverson JD; AbbVie Inc., North Chicago, IL., Ross JA; AbbVie Inc., North Chicago, IL., Maciag PC; AbbVie Inc., North Chicago, IL., Verdugo M; AbbVie Inc., North Chicago, IL., Touzeau C; Centre Hospitalier Universitaire de Nantes, INSERM, Université de Nantes, France.
Publikováno v:
Blood [Blood] 2017 Nov 30; Vol. 130 (22), pp. 2401-2409. Date of Electronic Publication: 2017 Oct 10.